pfizer

Marines Face Separation if Not Fully Vaccinated by End of November

Marine Sgt Maj. James Robertson, the sergeant major of Marine Corps Air Station (MCAS) Cherry Point receives the Moderna COVID-19 Vaccine at MCAS Cherry Point, North Carolina, on Dec. 23, 2020. US Marine Corps Photo

All active-duty Marines will need to be fully vaccinated against COVID-19 by Nov. 28 or face separation, according to new guidance from the Marine Corps.

The Marine Corps guidance, signed Saturday and released by Lt. Gen. D.J. Furness, deputy commandant, plans, policies and...

https://news.usni.org/2021/10/25/marines-face-separation-if-not-fully-vaccinated-by-end-of-november

Covax: How many Covid Vaccines Have The US And The Other G7 Countries Pledged?

UNICEF has urged leaders of the G7 group of countries – who are meeting in Cornwall this weekend – to speed up the donation of vaccines says a news article Published in BBC.

An open letter, signed by celebrity ambassadors including David Beckham, Andy Murray, and Katy Perry, says Covax is facing an urgent shortfall of 190 million doses.

The charity says G7 countries could donate 20 percent of their vaccine supply between June and August – over 150 million doses – without causing “significant...

https://mfame.guru/covax-how-many-covid-vaccines-have-the-us-and-the-other-g7-countries-pledged/

Pfizer and AstraZeneca Vaccines Effective Against A New Strain

  • The Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses, a study has found.
  • Two jabs of either vaccine give a similar level of protection against symptomatic disease from the Indian variant as they do for the Kent one.
  • However, both vaccines were only 33% effective against the Indian variant three weeks after the first dose.
  • This compared with 50% effectiveness against the Kent variant.

A recent news article published in...

https://mfame.guru/pfizer-and-astrazeneca-vaccines-effective-against-a-new-strain/

Indian Funds Its Vaccine Manufacturers With $610 million

India’s government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech to boost production capacity, says an article published in Reuters.

Serum Institute of India

SII, the world’s biggest maker of vaccines including the AstraZeneca shot, is funded with 30 billion rupees ($400 million).

SII sought the funds to increase its monthly capacity to more than 100 million doses by the end of May, from up to 70 million...

https://mfame.guru/indian-funds-610-million-to-its-vaccine-manufacturers/

US To ‘Pause’ Use Of J&J Vaccine Over Blood Clot Concerns

  • The FDA is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood-clotting disorder.
  • The FDA said the recommendation is “out of an abundance of caution.”
  • The cases occurred in women ages 18 to 48, with symptoms developing six to 13 days after they received the shot.

The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration are recommending a “pause” in the use of the single-dose Johnson & Johnson...

https://mfame.guru/us-to-pause-use-of-jj-vaccine-over-blood-clot-concerns/

Clinical Trials of Oral Antiviral Drug for Covid

  • Pfizer said it has begun an early stage clinical trial testing its experimental oral antiviral drug for Covid-19.
  • The company said the phase one trial of the drug – called PF-07321332 – is being conducted in the United States.
  • The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.

A recent news article published in CNBC written by Berkeley Lovelace Jr. reveals that Pfizer begins early stage...

https://mfame.guru/clinical-trials-of-oral-antiviral-drug-for-covid/

Pharma firms working together to make each other’s vaccines

Visual inspection of vaccine vials at a Merck production facility. (Photo: Copyright © 2009-2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc., Kenilworth, New Jersey, U.S.A. All rights reserved.)

This is an excerpt from the March 16, 2021 edition of Medically Necessary, a health care supply chain newsletter. Subscribe here.

Good afternoon. Medically Necessary is a newsletter by Matt Blois about the health care supply chain — how we get drugs, devices and medical supplies to health care providers and patients.

Pharma firms working together to make each other’s vaccines

Visual inspection of vaccine vials at a Merck production facility. (Photo: Copyright © 2009-2020 Merck Sharp & Dohme Corp.,...

https://s29755.pcdn.co/news/pharma-firms-working-together-to-make-each-others-vaccines

Delay in Second Dose of Covid 19 Vaccine Anticipated

  • Within a couple weeks after a first vaccine dose, people are well protected against severe COVID-19, new data suggest.
  • With demand for shots far outpacing supply, that’s sparked a debate among scientists and policy makers: Is it OK to hold off giving the second dose?
  • Delaying the dose could make way for more people to get their first shots and stem the coronavirus’s spread, proponents say.
  • Opponents say there’s not enough data to show if that one-shot protection is long-lasting enough.
  • And...

https://mfame.guru/delay-in-second-dose-of-covid-19-vaccine-anticipated/

US Warned of Possible ‘Fourth Surge’ Amid Variants Spread

  • A potential fourth surge of cases in the US may be on the line owing to the pandemic spread.
  • The UK, South Africa and Brazil strains appear to be more contagious.
  • CDC warns that until more people are vaccinated, variants could drive a spike in cases.

A top health official has warned that the spread of highly contagious coronavirus variants is threatening to fuel a “potential fourth surge of cases,” reports BBC.

Surging new COVID cases

The head of the US Centers for Disease Control and Prevention...

https://mfame.guru/us-warned-of-possible-fourth-surge-amid-variants-spread/

+ More